Related Experiment Video
Updated: May 4, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy
E T D Hoey1, J K Teoh2, I Das1
1Department of Radiology, Heart of England NHS Foundation Trust, Birmingham, West Midlands, UK.
Insights
Hypertrophic cardiomyopathy (HCM) is a genetic heart condition. Cardiovascular magnetic resonance imaging (CMR) aids in risk stratification for sudden death (SD) by assessing myocardial fibrosis and hypertrophy.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease.
- Sudden death (SD) can be the first sign of HCM, often linked to arrhythmias caused by myocardial disorganization and scarring.
- Echocardiography may be inconclusive, necessitating advanced imaging techniques.
Purpose of the Study:
- To review the role of Cardiovascular Magnetic Resonance imaging (CMR) in risk stratification for sudden death (SD) in patients with Hypertrophic Cardiomyopathy (HCM).
- To highlight CMR's ability to assess key indicators of adverse prognosis in HCM.
Main Methods:
- Utilizes Cardiovascular Magnetic Resonance imaging (CMR) for non-invasive assessment.
- Employs inversion recovery gadolinium-enhanced sequences to evaluate myocardial fibrosis.
- Assesses biventricular function and wall thickness.
Main Results:
- CMR provides precise assessment of biventricular function, wall thickness, and myocardial fibrosis.
- Recent research using CMR has identified potential adverse prognostic indicators for SD in HCM.
- CMR findings offer insights into the electrophysiological substrate of HCM.
Conclusions:
- CMR is crucial for diagnosing HCM and assessing risk, especially when echocardiography is inconclusive.
- CMR is a promising research tool, identifying new prognostic indicators for SD.
- Integrating CMR findings into existing risk algorithms is essential for improved patient management.
Abstract:
Hypertrophic cardiomyopathy (HCM) is the most common inheritable cardiovascular disorder. Although many HCM patients remain asymptomatic, sudden death (SD) can occur as the initial manifestation of the disease. It has been hypothesized that myocardial architectural disorganization and scarring represent an unstable electrophysiological substrate that creates susceptibility to malignant ventricular arrhythmias. Cardiovascular magnetic resonance imaging (CMR) is widely used for the diagnosis of HCM, especially in patients with an incomplete or inconclusive echocardiography study. CMR can provide precise non-invasive assessment of biventricular function, wall thickness, and assessment of myocardial fibrosis, using inversion recovery gadolinium-enhanced sequences. CMR is also one of the most promising avenues of research in HCM, and in recent years, has provided many new insights and identified a number of potential adverse prognostic indicators for SD. Future work is still needed to integrate CMR findings into traditional risk assessment algorithms. This paper reviews the evolving role of CMR for risk stratification in HCM including assessment of myocardial hypertrophy, fibrosis and ischaemia.
More Related Videos
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Imaging Studies for Cardiovascular System IV: CMRI
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT